Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reward | 16 | 2024 | 188 | 4.360 |
Why?
|
| Cocaine-Related Disorders | 6 | 2023 | 36 | 3.540 |
Why?
|
| Substance-Related Disorders | 14 | 2024 | 415 | 3.210 |
Why?
|
| Dextroamphetamine | 8 | 2021 | 108 | 2.870 |
Why?
|
| Motivation | 14 | 2023 | 296 | 2.700 |
Why?
|
| Anhedonia | 6 | 2023 | 11 | 2.400 |
Why?
|
| Emotions | 8 | 2021 | 349 | 2.000 |
Why?
|
| Central Nervous System Stimulants | 5 | 2021 | 219 | 1.950 |
Why?
|
| Hallucinogens | 5 | 2022 | 77 | 1.750 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 7 | 2020 | 70 | 1.450 |
Why?
|
| Behavior Therapy | 2 | 2024 | 87 | 1.410 |
Why?
|
| Decision Making | 7 | 2022 | 667 | 1.400 |
Why?
|
| Cocaine | 4 | 2023 | 76 | 1.390 |
Why?
|
| Social Behavior | 6 | 2014 | 299 | 1.290 |
Why?
|
| Double-Blind Method | 18 | 2022 | 1719 | 1.260 |
Why?
|
| Naltrexone | 2 | 2022 | 136 | 1.230 |
Why?
|
| Dopamine | 3 | 2022 | 276 | 1.180 |
Why?
|
| Neuropsychological Tests | 6 | 2020 | 505 | 1.170 |
Why?
|
| Stress Disorders, Post-Traumatic | 8 | 2022 | 115 | 1.170 |
Why?
|
| Adult | 45 | 2024 | 26607 | 1.140 |
Why?
|
| Depression | 3 | 2020 | 505 | 1.090 |
Why?
|
| Young Adult | 24 | 2024 | 6312 | 1.040 |
Why?
|
| Cognition | 3 | 2020 | 580 | 1.040 |
Why?
|
| Heart Rate | 10 | 2020 | 495 | 0.970 |
Why?
|
| Anger | 2 | 2024 | 80 | 0.950 |
Why?
|
| Psychomotor Performance | 8 | 2022 | 496 | 0.950 |
Why?
|
| Nicotine | 4 | 2022 | 199 | 0.940 |
Why?
|
| Inflammation | 2 | 2020 | 972 | 0.910 |
Why?
|
| Healthy Volunteers | 4 | 2018 | 146 | 0.890 |
Why?
|
| Memory, Short-Term | 3 | 2018 | 227 | 0.880 |
Why?
|
| Affect | 8 | 2023 | 387 | 0.830 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2013 | 69 | 0.820 |
Why?
|
| Tobacco Use Disorder | 4 | 2024 | 115 | 0.790 |
Why?
|
| Adolescent | 22 | 2024 | 9263 | 0.780 |
Why?
|
| Cannabis | 1 | 2022 | 35 | 0.770 |
Why?
|
| Dopamine Uptake Inhibitors | 2 | 2011 | 44 | 0.760 |
Why?
|
| Female | 48 | 2024 | 46202 | 0.760 |
Why?
|
| Male | 47 | 2024 | 42411 | 0.750 |
Why?
|
| Pleasure | 4 | 2023 | 14 | 0.730 |
Why?
|
| Humans | 59 | 2024 | 89357 | 0.720 |
Why?
|
| Intelligence | 2 | 2018 | 71 | 0.700 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 92 | 0.690 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2021 | 1942 | 0.690 |
Why?
|
| Dronabinol | 2 | 2022 | 56 | 0.670 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2018 | 19 | 0.650 |
Why?
|
| GTP-Binding Proteins | 1 | 2018 | 145 | 0.620 |
Why?
|
| Appetitive Behavior | 1 | 2018 | 15 | 0.610 |
Why?
|
| Conditioning, Classical | 1 | 2018 | 36 | 0.600 |
Why?
|
| Conditioning, Operant | 1 | 2018 | 71 | 0.590 |
Why?
|
| Cues | 6 | 2022 | 174 | 0.590 |
Why?
|
| Smoking | 7 | 2012 | 621 | 0.570 |
Why?
|
| Schizophrenia | 1 | 2020 | 483 | 0.570 |
Why?
|
| Stress, Psychological | 5 | 2020 | 322 | 0.550 |
Why?
|
| Cytokines | 1 | 2020 | 803 | 0.550 |
Why?
|
| Dopamine Agents | 1 | 2016 | 28 | 0.550 |
Why?
|
| Levodopa | 1 | 2016 | 36 | 0.550 |
Why?
|
| Speech | 2 | 2020 | 85 | 0.530 |
Why?
|
| Facial Recognition | 1 | 2016 | 16 | 0.530 |
Why?
|
| Drug Tolerance | 1 | 2015 | 64 | 0.520 |
Why?
|
| Motor Activity | 1 | 2018 | 327 | 0.510 |
Why?
|
| Ethanol | 2 | 2015 | 250 | 0.510 |
Why?
|
| Social Perception | 1 | 2016 | 95 | 0.500 |
Why?
|
| Exercise | 1 | 2018 | 323 | 0.500 |
Why?
|
| Attention | 2 | 2018 | 395 | 0.490 |
Why?
|
| Euphoria | 2 | 2011 | 43 | 0.490 |
Why?
|
| Narcotic Antagonists | 1 | 2016 | 160 | 0.470 |
Why?
|
| Photic Stimulation | 5 | 2018 | 501 | 0.470 |
Why?
|
| Oxycodone | 1 | 2014 | 35 | 0.460 |
Why?
|
| Frontal Lobe | 1 | 2014 | 132 | 0.440 |
Why?
|
| Basal Ganglia | 1 | 2013 | 46 | 0.430 |
Why?
|
| Blood Pressure | 6 | 2016 | 900 | 0.430 |
Why?
|
| Firefighters | 2 | 2023 | 2 | 0.430 |
Why?
|
| Interpersonal Relations | 1 | 2014 | 175 | 0.420 |
Why?
|
| Amygdala | 1 | 2013 | 86 | 0.420 |
Why?
|
| Trust | 1 | 2013 | 98 | 0.410 |
Why?
|
| Verbal Behavior | 1 | 2012 | 32 | 0.410 |
Why?
|
| Empathy | 1 | 2014 | 151 | 0.400 |
Why?
|
| Alcoholism | 2 | 2024 | 178 | 0.400 |
Why?
|
| Executive Function | 1 | 2012 | 91 | 0.400 |
Why?
|
| Facial Expression | 1 | 2012 | 51 | 0.400 |
Why?
|
| Genotype | 3 | 2013 | 1849 | 0.390 |
Why?
|
| Caffeine | 1 | 2012 | 83 | 0.390 |
Why?
|
| Amphetamine | 1 | 2012 | 101 | 0.380 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 294 | 0.380 |
Why?
|
| Middle Aged | 17 | 2024 | 25974 | 0.350 |
Why?
|
| Affective Symptoms | 1 | 2010 | 50 | 0.350 |
Why?
|
| Unsafe Sex | 1 | 2010 | 45 | 0.350 |
Why?
|
| Analgesics, Opioid | 1 | 2014 | 444 | 0.340 |
Why?
|
| Psychological Tests | 3 | 2016 | 91 | 0.330 |
Why?
|
| Autonomic Nervous System | 3 | 2020 | 65 | 0.330 |
Why?
|
| Language | 2 | 2020 | 154 | 0.320 |
Why?
|
| Smoking Cessation | 2 | 2011 | 253 | 0.320 |
Why?
|
| Gambling | 2 | 2010 | 159 | 0.300 |
Why?
|
| Self Report | 5 | 2022 | 297 | 0.270 |
Why?
|
| Behavior, Addictive | 2 | 2024 | 134 | 0.260 |
Why?
|
| Alcohol Drinking | 3 | 2024 | 273 | 0.250 |
Why?
|
| Individuality | 3 | 2016 | 110 | 0.240 |
Why?
|
| Bayes Theorem | 2 | 2023 | 370 | 0.240 |
Why?
|
| Tobacco Use | 1 | 2024 | 27 | 0.240 |
Why?
|
| HIV Infections | 2 | 2010 | 840 | 0.230 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 1 | 2023 | 5 | 0.220 |
Why?
|
| Data Interpretation, Statistical | 2 | 2018 | 299 | 0.220 |
Why?
|
| Cholinergic Agents | 1 | 2022 | 17 | 0.210 |
Why?
|
| Reaction Time | 3 | 2015 | 310 | 0.210 |
Why?
|
| Craving | 2 | 2021 | 22 | 0.200 |
Why?
|
| Facial Muscles | 2 | 2012 | 23 | 0.200 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2022 | 11 | 0.200 |
Why?
|
| Mindfulness | 1 | 2021 | 12 | 0.200 |
Why?
|
| Recreation | 1 | 2021 | 8 | 0.200 |
Why?
|
| Sex Characteristics | 3 | 2013 | 326 | 0.190 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 166 | 0.190 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 1723 | 0.180 |
Why?
|
| Laboratories | 1 | 2020 | 44 | 0.170 |
Why?
|
| Pilot Projects | 1 | 2022 | 871 | 0.170 |
Why?
|
| Cigarette Smoking | 1 | 2020 | 35 | 0.170 |
Why?
|
| Psychotropic Drugs | 1 | 2020 | 78 | 0.170 |
Why?
|
| Personality | 2 | 2011 | 134 | 0.160 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2758 | 0.160 |
Why?
|
| Galvanic Skin Response | 1 | 2018 | 12 | 0.150 |
Why?
|
| Surveys and Questionnaires | 4 | 2015 | 2624 | 0.150 |
Why?
|
| Physical Fitness | 1 | 2018 | 51 | 0.150 |
Why?
|
| Hunger | 1 | 2018 | 23 | 0.150 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 1671 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 345 | 0.150 |
Why?
|
| Psychophysics | 1 | 2018 | 80 | 0.150 |
Why?
|
| Adolescent Behavior | 2 | 2011 | 109 | 0.150 |
Why?
|
| Oxytocin | 2 | 2020 | 73 | 0.150 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 1714 | 0.150 |
Why?
|
| Marijuana Abuse | 2 | 2015 | 26 | 0.150 |
Why?
|
| Arousal | 1 | 2018 | 170 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 2401 | 0.150 |
Why?
|
| Electromyography | 1 | 2018 | 193 | 0.150 |
Why?
|
| Aged | 4 | 2024 | 19165 | 0.140 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 492 | 0.140 |
Why?
|
| Social Environment | 1 | 2018 | 187 | 0.140 |
Why?
|
| Receptors, Oxytocin | 1 | 2016 | 10 | 0.130 |
Why?
|
| Games, Experimental | 2 | 2013 | 11 | 0.130 |
Why?
|
| Machine Learning | 1 | 2018 | 258 | 0.130 |
Why?
|
| Attentional Bias | 1 | 2015 | 8 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2018 | 491 | 0.130 |
Why?
|
| Drug Users | 1 | 2015 | 21 | 0.130 |
Why?
|
| Personality Inventory | 1 | 2015 | 109 | 0.130 |
Why?
|
| Computational Biology | 1 | 2018 | 543 | 0.130 |
Why?
|
| Respiratory Sinus Arrhythmia | 1 | 2014 | 2 | 0.120 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2014 | 9 | 0.120 |
Why?
|
| Impulsive Behavior | 1 | 2018 | 287 | 0.120 |
Why?
|
| Gene Expression | 1 | 2018 | 1310 | 0.120 |
Why?
|
| Time Factors | 3 | 2018 | 5338 | 0.120 |
Why?
|
| Case-Control Studies | 3 | 2015 | 1862 | 0.110 |
Why?
|
| Functional Neuroimaging | 1 | 2013 | 31 | 0.110 |
Why?
|
| Signal Detection, Psychological | 1 | 2013 | 20 | 0.110 |
Why?
|
| United States | 2 | 2024 | 6989 | 0.110 |
Why?
|
| Animals | 2 | 2024 | 27371 | 0.110 |
Why?
|
| Hydrocortisone | 2 | 2012 | 302 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1719 | 0.100 |
Why?
|
| Homozygote | 1 | 2012 | 204 | 0.100 |
Why?
|
| Sensory Thresholds | 1 | 2012 | 55 | 0.100 |
Why?
|
| Cadherins | 1 | 2012 | 163 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 3448 | 0.100 |
Why?
|
| Word Association Tests | 1 | 2011 | 5 | 0.100 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 190 | 0.100 |
Why?
|
| Mutation, Missense | 1 | 2012 | 277 | 0.100 |
Why?
|
| Writing | 1 | 2011 | 29 | 0.090 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2011 | 47 | 0.090 |
Why?
|
| Factor Analysis, Statistical | 1 | 2011 | 114 | 0.090 |
Why?
|
| Probability | 1 | 2011 | 353 | 0.090 |
Why?
|
| Models, Psychological | 1 | 2011 | 158 | 0.090 |
Why?
|
| Brain Mapping | 1 | 2014 | 564 | 0.090 |
Why?
|
| Pattern Recognition, Visual | 1 | 2012 | 155 | 0.090 |
Why?
|
| Visual Perception | 1 | 2014 | 326 | 0.090 |
Why?
|
| Stroop Test | 1 | 2010 | 9 | 0.090 |
Why?
|
| Intelligence Tests | 1 | 2010 | 38 | 0.090 |
Why?
|
| HIV Seropositivity | 1 | 2010 | 51 | 0.090 |
Why?
|
| Saliva | 1 | 2011 | 124 | 0.090 |
Why?
|
| Drug Interactions | 1 | 2010 | 245 | 0.080 |
Why?
|
| Memory | 1 | 2011 | 220 | 0.080 |
Why?
|
| Alleles | 1 | 2013 | 1135 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 374 | 0.080 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 219 | 0.080 |
Why?
|
| DNA Repeat Expansion | 1 | 2007 | 4 | 0.080 |
Why?
|
| Anxiety | 1 | 2010 | 308 | 0.080 |
Why?
|
| Placebos | 3 | 2013 | 214 | 0.070 |
Why?
|
| Recurrence | 1 | 2011 | 1144 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 588 | 0.070 |
Why?
|
| Ataxia | 1 | 2007 | 39 | 0.070 |
Why?
|
| Communication | 1 | 2011 | 460 | 0.070 |
Why?
|
| Administration, Intranasal | 2 | 2020 | 137 | 0.070 |
Why?
|
| Object Attachment | 1 | 2006 | 19 | 0.070 |
Why?
|
| Nicotinic Agonists | 1 | 2007 | 73 | 0.070 |
Why?
|
| Learning | 1 | 2009 | 285 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2013 | 2872 | 0.070 |
Why?
|
| Universities | 1 | 2006 | 148 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2012 | 2303 | 0.060 |
Why?
|
| Students | 1 | 2006 | 170 | 0.060 |
Why?
|
| Electrocardiography | 2 | 2018 | 494 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 726 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2023 | 389 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2023 | 166 | 0.050 |
Why?
|
| Smokers | 1 | 2021 | 46 | 0.050 |
Why?
|
| Breath Tests | 2 | 2011 | 57 | 0.050 |
Why?
|
| Syndrome | 1 | 2021 | 449 | 0.050 |
Why?
|
| Psycholinguistics | 1 | 2020 | 10 | 0.040 |
Why?
|
| Self Concept | 2 | 2013 | 133 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2016 | 899 | 0.040 |
Why?
|
| Semantics | 1 | 2020 | 48 | 0.040 |
Why?
|
| Evoked Potentials | 1 | 2021 | 190 | 0.040 |
Why?
|
| Biomarkers | 2 | 2019 | 1767 | 0.040 |
Why?
|
| Carbon Monoxide | 2 | 2010 | 93 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2020 | 8241 | 0.040 |
Why?
|
| Heart | 1 | 2020 | 574 | 0.030 |
Why?
|
| Urban Population | 1 | 2018 | 224 | 0.030 |
Why?
|
| Poverty | 1 | 2018 | 180 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 69 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 160 | 0.030 |
Why?
|
| Heterozygote | 1 | 2016 | 373 | 0.030 |
Why?
|
| Pregnanolone | 1 | 2012 | 8 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1840 | 0.030 |
Why?
|
| Smoking Prevention | 1 | 2012 | 45 | 0.030 |
Why?
|
| Linear Models | 1 | 2014 | 421 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2014 | 160 | 0.030 |
Why?
|
| Brain | 1 | 2022 | 2285 | 0.030 |
Why?
|
| Introns | 1 | 2012 | 299 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 4289 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 781 | 0.020 |
Why?
|
| Alcoholic Intoxication | 1 | 2010 | 32 | 0.020 |
Why?
|
| Forecasting | 1 | 2011 | 306 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1072 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 234 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2012 | 945 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 1489 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 529 | 0.020 |
Why?
|
| Phenotype | 1 | 2012 | 2440 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 895 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2007 | 685 | 0.020 |
Why?
|
| Pedigree | 1 | 2007 | 970 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2006 | 222 | 0.020 |
Why?
|
| Chicago | 1 | 2006 | 1427 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 5499 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 6811 | 0.010 |
Why?
|